FIS (NYSE: FIS) made its AML Investigations Agent commercially available to any U.S.-based bank on October 15, 2026 — the first governed, frontier-reasoning-model AI agent designed for bank-grade anti ...
Panelists discuss how emerging therapies like menin inhibitors show promise based on strong preclinical data and clinical responses, while CD47 inhibitors have faced setbacks in phase 3 trials, with ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The article by Lachowiez et al titled “Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model” (J Clin Oncol 10. ...
Developed by FIS with support from Anthropic, the FIS AML Agent is now commercially available to any U.S.-based bank, including those that are not FIS clients today. At Amalgamated Bank, one of FIS’ ...